☰

Michelle A. Favila, Ph.D. - Publications

Affiliations: 
2013 University of Notre Dame, Notre Dame, IN, United States 
Area:
Immunology, Parasitology, Vector Biology, Genetics, Genomics
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Duthie MS, Pereira L, Favila M, Hofmeyer KA, Reed SJ, Metangmo S, Townsend S, Laurance JD, Picone A, Misquith A, Hossain F, Ghosh P, Khan MAA, Guderian J, Bailor HR, et al. A defined subunit vaccine that protects against vector-borne visceral leishmaniasis. Npj Vaccines. 2: 23. PMID 29263878 DOI: 10.1038/s41541-017-0025-5  0.32
2016 Duthie MS, Favila M, Hofmeyer KA, Tutterrow YL, Reed SJ, Laurance JD, Picone A, Guderian J, Bailor HR, Vallur AC, Liang H, Mohamath R, Vergara J, Howard RF, Coler RN, et al. Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis. Vaccine. PMID 27142329 DOI: 10.1016/J.Vaccine.2016.04.067  0.308
2015 Favila MA, Geraci NS, Jayakumar A, Hickerson S, Mostrom J, Turco SJ, Beverley SM, McDowell MA. Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells. Plos Neglected Tropical Diseases. 9: e0004238. PMID 26630499 DOI: 10.1371/Journal.Pntd.0004238  0.718
2015 Coler RN, Duthie MS, Hofmeyer KA, Guderian J, Jayashankar L, Vergara J, Rolf T, Misquith A, Laurance JD, Raman VS, Bailor HR, Cauwelaert ND, Reed SJ, Vallur A, Favila M, et al. From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE. Clinical & Translational Immunology. 4: e35. PMID 26175894 DOI: 10.1038/Cti.2015.6  0.486
2014 Favila MA, Geraci NS, Zeng E, Harker B, Condon D, Cotton RN, Jayakumar A, Tripathi V, McDowell MA. Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction. Journal of Immunology (Baltimore, Md. : 1950). 192: 5863-72. PMID 24808365 DOI: 10.4049/Jimmunol.1203230  0.718
2013 Ricardo-Carter C, Favila M, Polando RE, Cotton RN, Bogard Horner K, Condon D, Ballhorn W, Whitcomb JP, Yadav M, Geister RL, Schorey JS, McDowell MA. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription. Parasite Immunology. 35: 409-20. PMID 23834512 DOI: 10.1111/Pim.12049  0.625
2012 Donovan MJ, Tripathi V, Favila MA, Geraci NS, Lange MC, Ballhorn W, McDowell MA. Indoleamine 2,3-dioxygenase (IDO) induced by Leishmania infection of human dendritic cells. Parasite Immunology. 34: 464-72. PMID 22803643 DOI: 10.1111/J.1365-3024.2012.01380.X  0.689
Show low-probability matches.